Joel Myers
Biographic Data
| ID | 8930790 |
|---|---|
| NAME | Joel Myers |
| GIVEN NAMES | Joel |
| FAMILY NAME | Myers |
| SIGNATURE | MYERS J |
| AFFILIATIONS | Bristol-Myers Squibb, Lawrenceville, NJ, USA |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2017 |
| H-INDEX | 0 |
Tolerability of central nervous system symptoms among HIV-1 infected efavirenz users
Efavirenz (EFV) is a non-nucleoside reverse transcriptase inhibitor indicated for treatment of HIV-1 infection. Despite concern over EFV tolerability in clinical trials and practice, particularly related to central nervous system (CNS) adverse events, some observational studies have shown high rates of EFV continuation at one year and low rates of CNS-related EFV substitution. The objective of this study was to further examine the real-world rate…
No prominent works on this page.
Tolerability of central nervous system symptoms among HIV-1 infected efavirenz users
Efavirenz (EFV) is a non-nucleoside reverse transcriptase inhibitor indicated for treatment of HIV-1 infection. Despite concern over EFV tolerability in clinical trials and practice, particularly related to central nervous system (CNS) adverse events, some observational studies have shown high rates of EFV continuation at one year and low rates of CNS-related EFV substitution. The objective of this study was to further examine the real-world rate…
Adverse effect (1 work) · Antiretroviral therapy (1 work) · Central nervous system (1 work) · Efavirenz (1 work) · Electronic medical record (1 work) · Family medicine (1 work) · HIV Research and Treatment (1 work) · HIV-related health complications and treatments (1 work) · HIV/AIDS drug development and treatment (1 work) · Internal Medicine (1 work)